NasdaqCM:AQB

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. More Details


Snowflake Analysis

Flawless balance sheet with limited growth.


Similar Companies

Share Price & News

How has AquaBounty Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AQB's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-9.3%

AQB

-2.6%

US Biotechs

-0.8%

US Market


1 Year Return

65.3%

AQB

33.7%

US Biotechs

18.0%

US Market

Return vs Industry: AQB exceeded the US Biotechs industry which returned 31.7% over the past year.

Return vs Market: AQB exceeded the US Market which returned 17.8% over the past year.


Shareholder returns

AQBIndustryMarket
7 Day-9.3%-2.6%-0.8%
30 Day-1.0%2.8%6.8%
90 Day6.4%-1.3%8.9%
1 Year65.3%65.3%36.0%33.7%20.7%18.0%
3 Year-37.9%-37.9%20.4%14.3%41.5%32.1%
5 Yearn/a14.4%6.1%84.6%63.8%

Price Volatility Vs. Market

How volatile is AquaBounty Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is AquaBounty Technologies undervalued compared to its fair value and its price relative to the market?

4.04x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AQB's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AQB's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AQB is unprofitable, so we can't compare its PE Ratio to the US Biotechs industry average.

PE vs Market: AQB is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AQB's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AQB is overvalued based on its PB Ratio (4x) compared to the US Biotechs industry average (3.3x).


Next Steps

Future Growth

How is AquaBounty Technologies forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

12.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AQB is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AQB is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AQB is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AQB's revenue (82.8% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: AQB's revenue (82.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AQB's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has AquaBounty Technologies performed over the past 5 years?

-15.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AQB is currently unprofitable.

Growing Profit Margin: AQB is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AQB is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.

Accelerating Growth: Unable to compare AQB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AQB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.2%).


Return on Equity

High ROE: AQB has a negative Return on Equity (-41.12%), as it is currently unprofitable.


Next Steps

Financial Health

How is AquaBounty Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: AQB's short term assets ($13.3M) exceed its short term liabilities ($2.0M).

Long Term Liabilities: AQB's short term assets ($13.3M) exceed its long term liabilities ($4.7M).


Debt to Equity History and Analysis

Debt Level: AQB's debt to equity ratio (14.4%) is considered satisfactory.

Reducing Debt: AQB's debt to equity ratio has reduced from 73.5% to 14.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AQB has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: AQB is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.


Next Steps

Dividend

What is AquaBounty Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AQB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AQB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AQB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AQB's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AQB's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Sylvia Wulf (62 yo)

1.75yrs

Tenure

US$973,997

Compensation

Ms. Sylvia A. Wulf has been Chief Executive Officer, President and Executive Director of AquaBounty Technologies, Inc. since January 1, 2019. Ms. Wulf served as Senior Vice President and President of the M ...


CEO Compensation Analysis

Compensation vs Market: Sylvia's total compensation ($USD974.00K) is about average for companies of similar size in the US market ($USD1.26M).

Compensation vs Earnings: Insufficient data to compare Sylvia's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Sylvia Wulf
CEO, President & Executive Director1.75yrsUS$974.00k0.45%
$ 801.0k
David Frank
CFO & Treasurer13yrsUS$314.91k0.13%
$ 237.9k
Alejandro Rojas
Chief Operating Officer of AquaBounty Farms6.67yrsUS$282.27k0.027%
$ 48.7k
Mark Walton
Chief Technology Officer1.17yrsno datano data
Angela Olsen
General Counsel & Corporate Secretary0.92yrno data0.067%
$ 120.2k
Dave Conley
Director of Communicationsno datano datano data
David Melbourne
Chief Commercial Officer1.33yrsno datano data
Louis Barnett
Financial Advisorno datano datano data

1.5yrs

Average Tenure

59yo

Average Age

Experienced Management: AQB's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Sylvia Wulf
CEO, President & Executive Director1.75yrsUS$974.00k0.45%
$ 801.0k
Richard Huber
Independent Non-Executive Director14.75yrsUS$63.69k0.14%
$ 245.2k
Richard Clothier
Independent Chairman of the Board14.5yrsUS$92.24k0.17%
$ 303.5k
Theodore Fisher
Non-Executive Director0.50yrno data0.00086%
$ 1.5k
Rick Sterling
Non-Executive Director7.08yrsno data0.0029%
$ 5.2k
Christine St. Clare
Independent Non-Executive Director6.42yrsUS$68.69k0.031%
$ 54.9k
James Turk
Independent Non-Executive Director7.67yrsUS$48.69k0.038%
$ 67.9k
Alana Czypinski
Non-Executive Director0.50yrno data0.0048%
$ 8.6k

6.8yrs

Average Tenure

63yo

Average Age

Experienced Board: AQB's board of directors are considered experienced (6.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AQB insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 107.9%.


Top Shareholders

Company Information

AquaBounty Technologies, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: AquaBounty Technologies, Inc.
  • Ticker: AQB
  • Exchange: NasdaqCM
  • Founded: 1991
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$179.668m
  • Shares outstanding: 44.92m
  • Website: https://www.aquabounty.com

Number of Employees


Location

  • AquaBounty Technologies, Inc.
  • 2 Mill and Main Place
  • Suite 395
  • Maynard
  • Massachusetts
  • 1754
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AQBNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDNov 2014
W8NBBST (Boerse-Stuttgart)YesCommon StockDEEURNov 2014

Biography

AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The comp ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/23 00:50
End of Day Share Price2020/10/22 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.